Insights

TLV publishes new pricing and reimbursement guidelines

New general guidelines and regulations on pricing and reimbursement in Sweden.

TLV has announced new general guidelines and regulations for pricing and reimbursement of medicines.

What changes

  • The guidelines consolidate assessment criteria for what constitutes a reasonable cost

  • Add criteria for price increases

  • Introduce a simplified application process for certain new drugs or formulations.

  • A revised handbook will be published on TLV’s website in late June 2026

Timeline

  • The new guidelines and regulations take effect from 1 October 2026.

  • On the same date, the current rules and general advice will cease to apply.

  • TLV will host a webinar on 2 September 2026 on practical application and the updated handbook.

Read more at https://www.tlv.se/press/nyheter/arkiv/2026-06-16-nya-allmanna-riktlinjer-och-foreskrifter-om-subvention-och-prissattning-av-lakemedel.html

Explore cutting-edge insights on optimizing health economics and market access